127 related articles for article (PubMed ID: 12183652)
1. Rapid desensitization of the serotonin(2C) receptor system: effector pathway and agonist dependence.
Stout BD; Clarke WP; Berg KA
J Pharmacol Exp Ther; 2002 Sep; 302(3):957-62. PubMed ID: 12183652
[TBL] [Abstract][Full Text] [Related]
2. Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus.
Berg KA; Maayani S; Goldfarb J; Scaramellini C; Leff P; Clarke WP
Mol Pharmacol; 1998 Jul; 54(1):94-104. PubMed ID: 9658194
[TBL] [Abstract][Full Text] [Related]
3. RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity.
Berg KA; Cropper JD; Niswender CM; Sanders-Bush E; Emeson RB; Clarke WP
Br J Pharmacol; 2001 Sep; 134(2):386-92. PubMed ID: 11564657
[TBL] [Abstract][Full Text] [Related]
4. Differences in rapid desensitization of 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptor-mediated phospholipase C activation.
Berg KA; Stout BD; Maayani S; Clarke WP
J Pharmacol Exp Ther; 2001 Nov; 299(2):593-602. PubMed ID: 11602671
[TBL] [Abstract][Full Text] [Related]
5. Pleiotropic behavior of 5-HT2A and 5-HT2C receptor agonists.
Berg KA; Maayani S; Goldfarb J; Clarke WP
Ann N Y Acad Sci; 1998 Dec; 861():104-10. PubMed ID: 9928246
[TBL] [Abstract][Full Text] [Related]
6. Novel actions of inverse agonists on 5-HT2C receptor systems.
Berg KA; Stout BD; Cropper JD; Maayani S; Clarke WP
Mol Pharmacol; 1999 May; 55(5):863-72. PubMed ID: 10220565
[TBL] [Abstract][Full Text] [Related]
7. Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols.
Cussac D; Newman-Tancredi A; Quentric Y; Carpentier N; Poissonnet G; Parmentier JG; Goldstein S; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):242-52. PubMed ID: 11882920
[TBL] [Abstract][Full Text] [Related]
8. Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves.
Kurrasch-Orbaugh DM; Watts VJ; Barker EL; Nichols DE
J Pharmacol Exp Ther; 2003 Jan; 304(1):229-37. PubMed ID: 12490596
[TBL] [Abstract][Full Text] [Related]
9. Agonist-induced functional desensitization of recombinant human 5-HT2 receptors expressed in CHO-K1 cells.
Porter RH; Malcolm CS; Allen NH; Lamb H; Revell DF; Sheardown MJ
Biochem Pharmacol; 2001 Aug; 62(4):431-8. PubMed ID: 11448452
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxyl]-5-pyridyl]carbamoyl]-6-trifluoromethylindone (SB 243213) on 5-hydroxytryptamine(2C) receptor-mediated responses.
Berg KA; Navailles S; Sanchez TA; Silva YM; Wood MD; Spampinato U; Clarke WP
J Pharmacol Exp Ther; 2006 Oct; 319(1):260-8. PubMed ID: 16807362
[TBL] [Abstract][Full Text] [Related]
11. Serotonin (5-HT) receptor subtypes mediate specific modes of 5-HT-induced signaling and regulation of neurosecretion in gonadotropin-releasing hormone neurons.
Wada K; Hu L; Mores N; Navarro CE; Fuda H; Krsmanovic LZ; Catt KJ
Mol Endocrinol; 2006 Jan; 20(1):125-35. PubMed ID: 16109737
[TBL] [Abstract][Full Text] [Related]
12. Temporal regulation of agonist efficacy at 5-hydroxytryptamine (5-HT)1A and 5-HT 1B receptors.
Berg KA; Evans KL; Cropper JD; Clarke WP
J Pharmacol Exp Ther; 2003 Jan; 304(1):200-5. PubMed ID: 12490592
[TBL] [Abstract][Full Text] [Related]
13. An innovative method for rapid characterisation of phospholipase C activity: SB242,084 competitively antagonises 5-HT2C receptor-mediated [3H]phosphatidylinositol depletion.
Cussac D; Newman-Tancredi A; Quentric Y; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 2000 Feb; 361(2):221-3. PubMed ID: 10685880
[TBL] [Abstract][Full Text] [Related]
14. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of regulation of agonist efficacy at the 5-HT(1A) receptor by phospholipid-derived signaling components.
Evans KL; Cropper JD; Berg KA; Clarke WP
J Pharmacol Exp Ther; 2001 Jun; 297(3):1025-35. PubMed ID: 11356925
[TBL] [Abstract][Full Text] [Related]
16. 5-hydroxytryptamine2C receptor activation inhibits 5-hydroxytryptamine1B-like receptor function via arachidonic acid metabolism.
Berg KA; Maayani S; Clarke WP
Mol Pharmacol; 1996 Oct; 50(4):1017-23. PubMed ID: 8863849
[TBL] [Abstract][Full Text] [Related]
17. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes.
Newman-Tancredi A; Cussac D; Quentric Y; Touzard M; Verrièle L; Carpentier N; Millan MJ
J Pharmacol Exp Ther; 2002 Nov; 303(2):815-22. PubMed ID: 12388668
[TBL] [Abstract][Full Text] [Related]
18. Rapid desensitization of serotonin 5-HT2C receptor-stimulated intracellular calcium mobilization in CHO cells transfected with cloned human 5-HT2C receptors.
Akiyoshi J; Nishizono A; Yamada K; Nagayama H; Mifune K; Fujii I
J Neurochem; 1995 Jun; 64(6):2473-9. PubMed ID: 7760026
[TBL] [Abstract][Full Text] [Related]
19. Characterization of human 5-HT4(d) receptor desensitization in CHO cells.
Mialet J; Fischmeister R; Lezoualc'h F
Br J Pharmacol; 2003 Feb; 138(3):445-52. PubMed ID: 12569069
[TBL] [Abstract][Full Text] [Related]
20. Interactions between effectors linked to serotonin receptors.
Berg KA; Maayani S; Clarke WP
Ann N Y Acad Sci; 1998 Dec; 861():111-20. PubMed ID: 9928247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
